Timberlyne Therapeutics

San Diego, CA · Founded 2024 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop and commercialize therapies for autoimmune diseases. Timberlyne Therapeutics is based in San Diego, CA and was founded in 2024. Its last reported valuation was $324 million in Jan 2025. It has raised $180 million.

Last reported valuation
$324.2M
Oct 2026
Priced at
—
Total raised
$180.0M
Last round
—

Who backs Timberlyne Therapeutics?

7 investors
InvestorType
VenrockVenture capital
Boyu CapitalVenture capital
Bain Capital Life SciencesVenture capital
BraidwellHedge fund
3H Health Investment—
Abingworth—
LAV (Lilly Asia Fund)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Timberlyne Therapeutics investors

7 investors are on record for Timberlyne Therapeutics, including Venrock, Boyu Capital, Bain Capital Life Sciences and Braidwell.

Free account
More of Timberlyne Therapeutics with a free account
  • ·Watch Timberlyne Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Timberlyne Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View